ALZN (alzamend.com) יחס שווי שוק לשווי בספרים

Alzamend Neuro, Inc. (ALZN) is implementing the LiPRO method for the safe delivery of lithium to the brain to halt Alzheimer's. This chart from the GURU.Markets terminal illustrates the price-to-book value trend, where the current figure stands at 0.94. A production outsourcing model minimizes costs, while strong private support is coupled with cautious expectations from experts.

This ratio compares the market value of Alzamend Neuro, Inc. (ALZN) to its net assets, determining the degree of asset overvaluation. For a company whose clinical trial costs are growing faster than revenues, this metric reflects market optimism regarding future discoveries. The current P/B ratio of Alzamend Neuro, Inc. (ALZN) stands at 0.94, capturing the real-time investor consensus. The trend for this indicator reveals hidden phases of business cooling. A high value signals the risk of overpaying for capital.